• LAST PRICE
    4.5500
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    4.4500/ 1
  • Ask / Lots
    4.4900/ 1
  • Open / Previous Close
    4.5200 / 4.5500
  • Day Range
    Low 4.3500
    High 4.6043
  • 52 Week Range
    Low 3.3500
    High 7.8500
  • Volume
    103,590
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 4.55
TimeVolumeLJPC
09:32 ET2134.52
09:35 ET1004.42
09:39 ET13084.5306
09:46 ET1004.56
09:51 ET10004.504
09:53 ET39424.497
09:57 ET4004.49
10:00 ET4004.45
10:06 ET5004.4243
10:08 ET7004.3801
10:11 ET4004.39
10:29 ET13064.43
10:31 ET41004.4564
10:33 ET2004.51
10:42 ET22004.51
10:44 ET25354.505
10:47 ET1004.51
10:51 ET19374.58
10:54 ET5004.58
10:56 ET5004.59
10:58 ET2004.58
11:00 ET4004.56
11:02 ET1294.5274
11:03 ET3004.56
11:05 ET3004.56
11:07 ET1004.55
11:12 ET13874.4537
11:25 ET13004.57
11:27 ET54204.59
11:30 ET27004.6
11:32 ET1004.58
11:38 ET3004.58
11:41 ET3004.56
11:43 ET1004.56
11:45 ET2004.56
11:48 ET2004.56
11:50 ET1004.545
11:59 ET1004.555
12:08 ET15004.57
12:10 ET12284.57
12:12 ET2004.53
12:19 ET6004.54
12:21 ET1004.54
12:24 ET1004.535
12:26 ET1004.53
12:28 ET1004.53
12:35 ET18064.55
12:37 ET2004.55
12:39 ET12004.54
12:42 ET3584.4801
12:50 ET10004.515
12:53 ET1004.51
01:11 ET7004.53
01:13 ET1004.535
01:15 ET17004.53
01:22 ET1004.52
01:24 ET2004.51
01:26 ET2004.51
01:31 ET2004.5
01:33 ET1004.5
01:38 ET1004.5
01:40 ET1004.5
01:42 ET2004.485
01:51 ET14304.52
01:56 ET1004.525
02:00 ET8004.52
02:02 ET1004.49
02:05 ET1004.49
02:07 ET7004.5
02:20 ET16844.54
02:23 ET3004.55
02:27 ET9004.535
02:34 ET1004.53
02:36 ET1004.53
02:38 ET2004.53
02:39 ET2004.53
02:41 ET49954.41
02:43 ET27244.37
02:45 ET33554.3702
02:48 ET1004.395
02:52 ET1004.4
02:56 ET2004.43
02:57 ET2004.415
02:59 ET4004.4281
03:01 ET8004.42
03:03 ET2004.42
03:06 ET1004.41
03:08 ET17674.35
03:10 ET10004.3739
03:12 ET5004.37
03:15 ET3004.4
03:17 ET3004.42
03:32 ET1004.42
03:33 ET1004.51
03:35 ET1004.455
03:42 ET27514.49
03:44 ET15004.57
03:46 ET14804.56
03:50 ET1704.539
03:51 ET23504.51
03:55 ET12104.505
03:57 ET24004.53
04:00 ET34114.55
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesLJPC
La Jolla Pharmaceutical Co
125.2M
14.1x
---
United StatesOPNT
Opiant Pharmaceuticals Inc
121.0M
528.7x
---
United StatesDRRX
DURECT Corp
150.1M
-3.8x
---
United StatesCSBR
Champions Oncology Inc
107.8M
301.5x
---
United StatesFREQ
Frequency Therapeutics Inc
166.8M
-2.2x
---
United StatesBFRA
Biofrontera AG
78.1M
-4.1x
---
As of 2022-01-22

Company Information

La Jolla Pharmaceutical Company is engaged in development and commercialization of therapies for patients suffering from life-threatening diseases. Its product pipeline include GIAPREZA (angiotensin II) and XERAVA (eravacycline). Its GIAPREZA (angiotensin II) injection is a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock. The GIAPREZA is used for the treatment of refractory hypotension in adults with septic or other distributive shock. Its XERAVA (eravacycline) is a tetracycline class antibacterial indicated for the treatment of complicated intra-abdominal infections (cIAI) in adults. The Company's early-stage clinical development product candidate include TP-6076, TP-271, and TP-2846. Its TP-6076 is a IV formulation of a fully synthetic fluorocycline derivative for the treatment of certain multidrug-resistant gram-negative bacteria. Its TP-2846, an IV formulation of a tetracycline for the treatment of acute myeloid leukemia.

Contact Information

Headquarters
201 JONES ROAD, SUITE 400WALTHAM, MA, United States 02451
Phone
617-715-3600
Fax
619-452-6893

Executives

Chairman of the Board
Kevin Tang
President, Chief Executive Officer, Director
Larry Edwards
Chief Financial Officer
Michael Hearne
Chief Medical Officer
Tony Hodges
Independent Director
Laura Douglass

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$125.2M
Revenue (TTM)
$74.5M
Shares Outstanding
27.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.16
EPS
$0.32
Book Value
$-3.21
P/E Ratio
14.1x
Price/Sales (TTM)
1.7
Price/Cash Flow (TTM)
8.9x
Operating Margin
24.74%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.